Concepedia
Statistics
Publications
4
Citations
229
H-Index
Active since
2007
Affiliations
Stanford University(Current)
Novartis (Switzerland)
Oregon Health & Science University
Dana-Farber Cancer Institute
Washington University in St. Louis
Andrea Linder is an author at Stanford University specializing in mast cell activation, life sciences, and mast cell disorders.
Publications per year
2007–2024
Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial
Daniel J. DeAngelo, Tracy I. George, Andrea Linder et al. · Leukemia · 2017 · 140 citations
Life Sciences, Immunology, Pharmacotherapy +9
KIT Inhibitor Midostaurin Exhibits a High Rate of Clinically Meaningful and Durable Responses in Advanced Systemic Mastocytosis: Report of a Fully Accrued Phase II Trial
Jason Gotlib, Daniel J. DeAngelo, Tracy I. George et al. · Blood · 2010 · 52 citations
Life Sciences, Immunology, Pharmacology +12
The KIT Tyrosine Kinase Inhibitor Midostaurine (PKC412) Exhibits a High Response Rate in Aggressive Systemic Mastocytosis (ASM): Interim Results of a Phase II Trial.
Jason Gotlib, Tracy I. George, C. L. Corless et al. · Blood · 2007 · 21 citations
Life Sciences, Immunology, Pharmacology +17
One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy
Daniel Seung Kim, Emily L. Chu, Emily Keamy-Minor et al. · Frontiers in Cardiovascular Medicine · 2024 · 16 citations · Full text
Medicine, Cardiology, Pharmacology +13
1–4 of 4